Shares of Cencora Inc. COR inched 0.47% higher to $249.97 Wednesday, on what proved to be an all-around favorable trading ...

Leading medical distributors McKesson (NYSE:MCK) and Cencora (NYSE:COR) will have to pay $266M in damages to Baltimore after ...

The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an ...

CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has reported impressive financial results for its fiscal year 2024 fourth ...

Upon closing, the acquisition of RCA is expected to be approximately $0.35 accretive, net of estimated financing costs, to ...

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal.  | ...

Revenue: US$294.0b (up 12% from FY 2023). Net income: US$1.51b (down 14% from FY 2023). Profit margin: 0.5% (down from 0.7% ...

In a report released yesterday, Steve Baxter from Wells Fargo maintained a Hold rating on Cencora (COR – Research Report), with a price ...

Analyst Charles Rhyee of TD Cowen maintained a Buy rating on Cencora (COR – Research Report), with a price target of $288.00. Charles ...

Cencora ( (COR) ) just unveiled an update. Cencora, Inc. reported significant growth in its fiscal 2024 results, boasting a ...

Summit Global Investments acquired a new stake in Cencora, Inc. (NYSE:COR – Free Report) in the 3rd quarter, ...

Cencora will potentially pay up to $500 million in aggregate contingent consideration in fiscal years 2027 and 2028.